NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR t cells take on autoimmune diseases in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called HBI0101 CAR T for people with severe autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis that haven't improved with standard care. The treatment uses a patient's own immune cells, modified to target and …
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)
Phase: PHASE1 • Sponsor: Polina Stepensky • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in 6 people with severe autoimmune diseases like multiple sclerosis and myasthenia gravis that haven't responded to standard treatments. The therapy uses specially engineered immune cells to target and calm the overacti…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New study monitors ultomiris safety for pregnant women and their babies
Knowledge-focused Recruiting nowThis study looks at the safety of the drug Ultomiris when used during pregnancy. Researchers will track 75 pregnant or postpartum women who take Ultomiris for conditions like PNH or aHUS. They will record pregnancy complications, maternal health issues, and infant health outcomes…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC